Back to Journals » Risk Management and Healthcare Policy » Volume 1

The costs of breast cancer in a Mexican public health institution

Authors Gómez-Rico JA, Altagracia-Martínez M, Kravzov-Jinich J, Cárdenas-Elizalde R, Rubio-Poo C

Published 24 November 2008 Volume 2008:1 Pages 15—21


Review by Single-blind

Peer reviewer comments 4

Jacobo Alejandro Gómez-Rico1, Marina Altagracia-Martínez1, Jaime Kravzov-Jinich1, Rosario Cárdenas-Elizalde1, Consuelo Rubio-Poo2

1Universidad Autónoma Metropolitano–Xochimilco (UAM-X), Departments: Biological Systems and Healthcare, Biological and Health Sciences Division (DCBS); 2Universidad Nacional Autónoma de México (UNAM), Faculty of Professional Studies-Zaragoza (FES-Zaragoza)

Abstract: Breast cancer (BC) is the second leading cause of death as a result of neoplasia in Mexico. This study aimed to identify the direct and indirect costs of treating female outpatients diagnosed with BC at a Mexican public hospital. A cross-sectional, observational, analytical study was conducted. A total of 506 medical records were analyzed and 102 were included in the cost analysis. The micro-costing process was used to estimate treatment costs. A 17-item questionnaire was used to obtain information on direct and indirect costs. Of the 102 women with BC included in the study, 92.2% (94) were at Stage II, and only 7.8% at Stage I. Total direct costs over six months for the 82 women who had modified radical mastectomy (MRM) surgury were US$733,821.15. Total direct costs for the 15 patients with conservative surgery (CS) were US$138,190.39. We found that the total economic burden in the study population was much higher for patients with MRM than for patients with CS.

Keywords: breast cancer, Mexican women, direct and indirect costs

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]